Parkside Financial Bank & Trust’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Parkside Financial Bank & Trust's RPRX Position: Q2 2026 in Review
Parkside Financial Bank & Trust increased its Royalty Pharma (RPRX) stake by 9.9% in Q2 2026, buying an estimated $3.49K and bringing the position to 741 shares worth $41.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1113.
Parkside Financial Bank & Trust first reported a position in RPRX in Q2 2021 and has held it in 21 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Parkside Financial Bank & Trust held 741 shares of Royalty Pharma worth $41.5K as of Q2 2026.
- Parkside Financial Bank & Trust bought 67 Royalty Pharma shares in Q2 2026, an estimated $3.49K.
- Royalty Pharma made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1113 holding.
- Parkside Financial Bank & Trust first reported a position in Royalty Pharma in Q2 2021 and has held it in 21 quarters since.
- 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.